Tomohisa Okuno

487 total citations
27 papers, 377 citations indexed

About

Tomohisa Okuno is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tomohisa Okuno has authored 27 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tomohisa Okuno's work include Gastric Cancer Management and Outcomes (6 papers), Metastasis and carcinoma case studies (5 papers) and Cancer Cells and Metastasis (5 papers). Tomohisa Okuno is often cited by papers focused on Gastric Cancer Management and Outcomes (6 papers), Metastasis and carcinoma case studies (5 papers) and Cancer Cells and Metastasis (5 papers). Tomohisa Okuno collaborates with scholars based in Japan. Tomohisa Okuno's co-authors include Masaichi Ohira, Masakazu Yashiro, Yuichiro Miki, Kosei Hirakawa, Go Masuda, Shingo Togano, Kenji Kuroda, Yurie Yamamoto, Atsushi Sugimoto and Hiroaki Tanaka and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Tomohisa Okuno

24 papers receiving 375 citations

Peers

Tomohisa Okuno
Sulsal Haque United States
Nadeem S. Bhat United States
Tomohisa Okuno
Citations per year, relative to Tomohisa Okuno Tomohisa Okuno (= 1×) peers Xiangyan Jiang

Countries citing papers authored by Tomohisa Okuno

Since Specialization
Citations

This map shows the geographic impact of Tomohisa Okuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohisa Okuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohisa Okuno more than expected).

Fields of papers citing papers by Tomohisa Okuno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomohisa Okuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohisa Okuno. The network helps show where Tomohisa Okuno may publish in the future.

Co-authorship network of co-authors of Tomohisa Okuno

This figure shows the co-authorship network connecting the top 25 collaborators of Tomohisa Okuno. A scholar is included among the top collaborators of Tomohisa Okuno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomohisa Okuno. Tomohisa Okuno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamamoto, Yurie, Atsushi Sugimoto, Shingo Togano, et al.. (2022). Lipocalin-2 negatively regulates epithelial–mesenchymal transition through matrix metalloprotease-2 downregulation in gastric cancer. Gastric Cancer. 25(5). 850–861. 14 indexed citations
2.
Sugimoto, Atsushi, Tomohisa Okuno, Yurie Yamamoto, et al.. (2021). The clinicopathologic significance of Tks5 expression of peritoneal mesothelial cells in gastric cancer patients. PLoS ONE. 16(7). e0253702–e0253702. 5 indexed citations
3.
Yashiro, Masakazu, Yurie Yamamoto, Atsushi Sugimoto, et al.. (2021). Dipeptidyl Peptidase-4 from Cancer-associated Fibroblasts Stimulates the Proliferation of Scirrhous-type Gastric Cancer Cells. Anticancer Research. 42(1). 501–509. 7 indexed citations
4.
Sugimoto, Atsushi, Tomohisa Okuno, Yuichiro Miki, et al.. (2021). EMMPRIN in extracellular vesicles from peritoneal mesothelial cells stimulates the invasion activity of diffuse-type gastric cancer cells. Cancer Letters. 521. 169–177. 6 indexed citations
5.
Yashiro, Masakazu, Kenji Kuroda, Go Masuda, et al.. (2021). Clinical difference between fibroblast growth factor receptor 2 subclass, type IIIb and type IIIc, in gastric cancer. Scientific Reports. 11(1). 4698–4698. 17 indexed citations
6.
Togano, Shingo, Masakazu Yashiro, Go Masuda, et al.. (2021). Gastric cancer stem cells survive in stress environments via their autophagy system. Scientific Reports. 11(1). 20664–20664. 19 indexed citations
7.
Togano, Shingo, Masakazu Yashiro, Yuichiro Miki, et al.. (2020). Microscopic distance from tumor invasion front to serosa might be a useful predictive factor for peritoneal recurrence after curative resection of T3-gastric cancer. PLoS ONE. 15(1). e0225958–e0225958. 7 indexed citations
8.
Miki, Yuichiro, Masakazu Yashiro, Kenji Kuroda, et al.. (2020). Circulating CEA‐positive and EpCAM‐negative tumor cells might be a predictive biomarker for recurrence in patients with gastric cancer. Cancer Medicine. 10(2). 521–528. 17 indexed citations
9.
Kuroda, Kenji, Masakazu Yashiro, Yuichiro Miki, et al.. (2020). Circulating tumor cells with FGFR2 expression might be useful to identify patients with existing FGFR2‐overexpressing tumor. Cancer Science. 111(12). 4500–4509. 17 indexed citations
10.
Yashiro, Masakazu, Yurie Yamamoto, Atsushi Sugimoto, et al.. (2019). Feasibility of Identifying Patients at High Risk of Hereditary Gastric Cancer Based on Clinicopathological Variables. Anticancer Research. 39(9). 5057–5064. 2 indexed citations
11.
Yamamoto, Yurie, Kenji Kuroda, Atsushi Sugimoto, et al.. (2019). The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer. Anticancer Research. 39(12). 6645–6652. 36 indexed citations
12.
Kuroda, Kenji, Masakazu Yashiro, Yurie Yamamoto, et al.. (2019). The clinicopathological significance of Thrombospondin-4 expression in the tumor microenvironment of gastric cancer. PLoS ONE. 14(11). e0224727–e0224727. 22 indexed citations
13.
Okuno, Tomohisa, Masakazu Yashiro, Go Masuda, et al.. (2019). Establishment of a New Scirrhous Gastric Cancer Cell Line with FGFR2 Overexpression, OCUM-14. Annals of Surgical Oncology. 26(4). 1093–1102. 9 indexed citations
14.
Miki, Yuichiro, Masakazu Yashiro, Tomohisa Okuno, et al.. (2018). CD9-positive exosomes from cancer-associated fibroblasts stimulate the migration ability of scirrhous-type gastric cancer cells. British Journal of Cancer. 118(6). 867–877. 70 indexed citations
15.
Miki, Yuichiro, Masakazu Yashiro, Tomohisa Okuno, et al.. (2018). Clinico-pathological significance of exosome marker CD63 expression on cancer cells and stromal cells in gastric cancer. PLoS ONE. 13(9). e0202956–e0202956. 34 indexed citations
16.
Kasashima, Hiroaki, Masakazu Yashiro, Tomohisa Okuno, et al.. (2018). Significance of the Lysyl Oxidase Members Lysyl Oxidase Like 1, 3, and 4 in Gastric Cancer. Digestion. 98(4). 238–248. 46 indexed citations
17.
18.
Masuda, Go, et al.. (2014). A Case of Granulocyte-colony Stimulating Factor Producing Colon Cancer. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 75(4). 998–1004.
19.
Okuno, Tomohisa, et al.. (2014). [Advanced gastric cancer(Stage IV)leading to perforation during chemotherapy with S-1 plus cisplatin].. PubMed. 41(10). 1313–5. 2 indexed citations
20.
Kashiwagi, Shinichiro, Tomohisa Okuno, Yuka Asano, et al.. (2013). [Effectiveness of eribulin chemotherapy for squamous cell carcinoma of the breast].. PubMed. 40(12). 2369–71. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026